Sheila  Weinmann  to  Prognosis
                            
                            
                                This is a "connection" page, showing publications  Sheila  Weinmann  has written about  Prognosis.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.283
         
        
        
     
 
    
        
        - 
            Cellular senescence predicts breast cancer risk from benign breast disease biopsy images. Breast Cancer Res. 2025 Mar 11; 27(1):37.
            
            
                Score: 0.052
             
- 
            Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer. JNCI Cancer Spectr. 2022 May 02; 6(3).
            
            
                Score: 0.043
             
- 
            Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes. Nat Commun. 2021 11 03; 12(1):6341.
            
            
                Score: 0.041
             
- 
            External validation of the EORTC and NCCN bladder cancer recurrence and progression risk calculators in a U.S. community-based health system. Urol Oncol. 2020 02; 38(2):39.e21-39.e27.
            
            
                Score: 0.036
             
- 
            Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery. Eur Urol Oncol. 2019 09; 2(5):589-596.
            
            
                Score: 0.034
             
- 
            Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease. J Clin Oncol. 2017 Jun 20; 35(18):1991-1998.
            
            
                Score: 0.030
             
- 
            Effects of transitioning from conventional methods to liquid-based methods on unsatisfactory Papanicolaou tests: results from a multicenter US study. Cancer Cytopathol. 2013 Oct; 121(10):568-75.
            
            
                Score: 0.023
             
- 
            Cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ: comparison of ICD-9 codes and pathology results--Kaiser Permanente, United States, 2000-2005. Cancer Epidemiol Biomarkers Prev. 2013 Jun; 22(6):1129-32.
            
            
                Score: 0.023